REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 44 filers reported holding REPROS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $925,000 | -34.4% | 700,608 | +3.8% | 0.00% | – |
| Q3 2016 | $1,410,000 | +29.7% | 674,848 | 0.0% | 0.00% | – |
| Q2 2016 | $1,087,000 | +107.0% | 674,848 | +24.6% | 0.00% | – |
| Q1 2016 | $525,000 | -19.8% | 541,611 | 0.0% | 0.00% | – |
| Q4 2015 | $655,000 | -83.7% | 541,611 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $4,024,000 | -12.0% | 541,611 | -15.3% | 0.00% | 0.0% |
| Q2 2015 | $4,573,000 | -37.5% | 639,606 | -24.9% | 0.00% | 0.0% |
| Q1 2015 | $7,315,000 | -13.7% | 851,532 | +0.2% | 0.00% | 0.0% |
| Q4 2014 | $8,474,000 | +2.4% | 849,971 | +1.7% | 0.00% | 0.0% |
| Q3 2014 | $8,278,000 | -40.3% | 836,154 | +4.3% | 0.00% | -50.0% |
| Q2 2014 | $13,875,000 | -2.0% | 801,995 | +0.5% | 0.00% | 0.0% |
| Q1 2014 | $14,160,000 | +8.4% | 798,192 | +11.8% | 0.00% | 0.0% |
| Q4 2013 | $13,067,000 | -31.4% | 714,054 | +0.5% | 0.00% | -50.0% |
| Q3 2013 | $19,040,000 | +97.3% | 710,457 | +35.9% | 0.00% | +100.0% |
| Q2 2013 | $9,648,000 | – | 522,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allegis Investment Advisors, LLC | 342,709 | $569,000 | 0.29% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $638,000 | 0.07% |
| Alambic Investment Management, L.P. | 69,191 | $111,000 | 0.03% |
| Acrospire Investment Management LLC | 15,119 | $24,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,486 | $158,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 315,030 | $507,000 | 0.01% |
| SIMPLEX TRADING, LLC | 86,054 | $138,000 | 0.01% |
| A.R.T. Advisors, LLC | 34,315 | $55,000 | 0.00% |
| Mariner Wealth Advisors-Cincinnati, LLC | 11,000 | $18,000 | 0.00% |
| Renaissance Technologies | 561,713 | $904,000 | 0.00% |